Great talk #ACR20 @anisha_dua re:monitoring in GCA/TAK Remember different distributions in GCA/TAK Slick summary slides with pros/cons of each modality I find myself picking based on clinical context, suspected involvement/extent, and availability #ACRambassador https://t.co/euMGbwirG9